2026
Topic
Gene Regulatory Networks
Fillmore and his colleagues utilized gene regulatory network analysis to identify potential therapeutic agents for the treatment of coronary artery disease. This approach led to the discovery that auranofin, an FDA-approved drug for rheumatoid arthritis, attenuates inflammation and prevents the formation of foam cells. Their findings suggest that targeting specific regulatory networks can facilitate the repurposing of existing medications to reduce atherosclerotic plaque buildup.